Delivery Order SPE2DB22D2005-SPE2DB24FJJG0
Award Date 2/27/24
Potential Completion Date 2/28/24
Potential Value $5.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply DUPIXENT 300 MG/2 ML PEN 2ML medical products. The $35,276.49 award has a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 2025. This...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $3,885.26 to provide DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The contract has a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not associated with any set-aside program. This delivery order is issued under a larger indefinite delivery contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,059.09 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4563942820 DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The contract, valued at $6,609.40, has an ultimate completion date of April 11, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, valued up to $999,999,999.00 with a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,564,205,110 units of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The delivery order, valued at $26,135.63, has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA that serves as the primary contract vehicle for the company to...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The $13,218.88 contract has a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a larger indefinite delivery contract (IDC) with a maximum value of $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $5,542.67 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of 4564155597 DUPIXENT 300 MG/2 ML PEN 2ML, with an ultimate completion date of April 4, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which serves as the primary contract vehicle...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The contract has a potential value of $44,847.89 and a period of performance through January 31, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and will deliver the pharmaceuticals from its...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The contract has a potential value of $4,517.21 and a period of performance through February 20, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this award, which does not have a set-aside designation. Amerisourcebergen...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DUPIXENT 300 MG/2 ML PEN 2ML pharmaceuticals. The contract has a potential value of $15,810.06 and a completion date of March 6, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor delivering these specialty pharmaceutical products to support military treatment programs and...